These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29159795)

  • 1. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.
    Miaskowski C; Mastick J; Paul SM; Abrams G; Cheung S; Sabes JH; Kober KM; Schumacher M; Conley YP; Topp K; Smoot B; Mausisa G; Mazor M; Wallhagen M; Levine JD
    J Cancer Surviv; 2018 Apr; 12(2):234-245. PubMed ID: 29159795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.
    Miaskowski C; Paul SM; Mastick J; Abrams G; Topp K; Smoot B; Kober KM; Chesney M; Mazor M; Mausisa G; Schumacher M; Conley YP; Sabes JH; Cheung S; Wallhagen M; Levine JD
    J Pain Symptom Manage; 2018 Jul; 56(1):88-97. PubMed ID: 29524582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
    Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
    Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
    Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
    J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
    Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.
    Kober KM; Mazor M; Abrams G; Olshen A; Conley YP; Hammer M; Schumacher M; Chesney M; Smoot B; Mastick J; Paul SM; Levine JD; Miaskowski C
    J Pain Symptom Manage; 2018 Dec; 56(6):908-919.e3. PubMed ID: 30172061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
    Zhang X; Trendowski MR; Wilkinson E; Shahbazi M; Dinh PC; Shuey MM; ; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Huddart R; Martin NE; Sanchez VA; Frisina RD; Einhorn LH; Cox NJ; Travis LB; Dolan ME
    Cancer Med; 2022 Jul; 11(14):2801-2816. PubMed ID: 35322580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus.
    Cheung S; Henderson-Sabes J; Mastick J; Abrams G; Snowberg K; Alfaro E; Quinn M; Paul S; Cooper B; Wallhagen M; Conley Y; Levine J; Miaskowski C
    BMJ Support Palliat Care; 2023 Sep; 13(3):345-353. PubMed ID: 35896321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
    Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
    JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
    J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
    Pearson SE; Taylor J; Patel P; Baguley DM
    Int J Audiol; 2019 Nov; 58(11):685-695. PubMed ID: 31545660
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy-Induced Neuropathy in Cancer Survivors.
    Miaskowski C; Mastick J; Paul SM; Topp K; Smoot B; Abrams G; Chen LM; Kober KM; Conley YP; Chesney M; Bolla K; Mausisa G; Mazor M; Wong M; Schumacher M; Levine JD
    J Pain Symptom Manage; 2017 Aug; 54(2):204-218.e2. PubMed ID: 28063866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
    Pearson SE; Caimino C; Shabbir M; Baguley DM
    J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.
    ArdeshirRouhaniFard S; Dinh PC; Monahan PO; Fossa SD; Huddart R; Fung C; Song Y; Feldman DR; Hamilton RJ; Vaughn DJ; Martin NE; Kollmannsberger C; Einhorn L; Kroenke K; Travis LB
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1129-1138. PubMed ID: 33849970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
    Trendowski MR; Wheeler HE; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Einhorn LH; Travis LB; Dolan ME
    Clin Cancer Res; 2020 Dec; 26(24):6550-6558. PubMed ID: 32998964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors.
    Miaskowski C; Mastick J; Paul S; Wallhagen M; Abrams G; Levine JD
    J Cancer Surviv; 2023 Feb; 17(1):59-68. PubMed ID: 36454519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falls in persons with chemotherapy-induced peripheral neuropathy.
    Tofthagen C; Overcash J; Kip K
    Support Care Cancer; 2012 Mar; 20(3):583-9. PubMed ID: 21380613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Phillips OR; Baguley DM; Pearson SE; Akeroyd MA
    J Cancer Surviv; 2023 Feb; 17(1):40-58. PubMed ID: 36637633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.
    Fung C; Sesso HD; Williams AM; Kerns SL; Monahan P; Abu Zaid M; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Kollmannsberger CK; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Lipshultz SE; Einhorn LH; Fossa SD; Travis LB;
    J Clin Oncol; 2017 Apr; 35(11):1211-1222. PubMed ID: 28240972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-Induced Peripheral Neuropathy (CIPN) as a Predictor of Decreased Quality of Life in Testicular Germ Cell Tumor Survivors.
    Orszaghova Z; Galikova D; Lesko P; Obertova J; Rejlekova K; Sycova-Mila Z; Palacka P; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M; Chovanec M
    Clin Genitourin Cancer; 2024 Jun; 22(3):102067. PubMed ID: 38555680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.